Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (9): 1200-1213.doi: 10.12092/j.issn.1009-2501.2026.09.006

Previous Articles    

Cuiru Keli improves bromocriptine-induced postpartum hypogalactia in rats by regulating the WTAP-Wnt5a-β-catenin signaling axis

Hui LI1(), Qiuyun XUE1, Meiling YUAN1, Qiying JIN1, Jiaqing CHEN1, Aixin XIA1, Chenhao XU2,3,*(), Chenggui MIAO1,2,3,4,*()   

  1. 1. Department of Pharmacology, School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China
    2. Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China
    3. Experimental (Training) Teaching Center, School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China
    4. School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong 999077, China
  • Received:2025-01-10 Revised:2025-02-19 Online:2026-09-26 Published:2026-10-08
  • Contact: Chenhao XU,Chenggui MIAO E-mail:lhui09@126.com;935905919@qq.com;miaocg@ahtcm.edu.cn

Abstract:

AIM: To study the effect and mechanism of Cuiru Keli (CRKL) on bromocriptine-induced postpartum hypogalactia in rats. METHODS: ELISA was used to detect the level of prolactin (PRL) in mammary tissue (MT) of postpartum hypogalactia. Cultivate rat mammary epithelial cells (RMECs) in vitro. The effect of CRKL on RMEC proliferation was detected by CCK8 method to determine the drug-containing serum. RT-qPCR and immunofluorescence detection of lactose, milk fat, and milk protein related gene expression. Network pharmacology predicts the signaling pathway of CRKL treatment for postpartum hypogalactia. Molecular docking and molecular dynamics verification of the binding between key components of CRKL and WTAP. RIP was used to study the interaction between WTAP and Wnt5a. RT-qPCR and Western blot were used to investigate the regulatory mechanism of CRKL on the Wnt/β-catenin signaling pathway. RESULTS: CRKL significantly increased the hourly milk production of female rats (P<0.05 or P<0.01). CRKL increases PRL levels in MT of model rats (P<0.01). Serum containing CRKL promotes the expression of PRLR, FASN, CSN2, and GLUT1 (all P<0.05 or P<0.01). Network pharmacology predicts a high correlation between the Wnt/β-catenin signaling pathway and CRKL treatment for postpartum hypogalactia. And the serum containing CRKL promotes the expression of key genes CCND1, c-Myc, and β-catenin in the Wnt signaling pathway (all P<0.05 or P<0.01). Molecular docking and molecular dynamics indicate that the key component of CRKL has strong binding ability with WTAP. Overexpression of WTAP in RMECs interferes with the function of CRKL (P<0.01). CONCLUSION: CRKL improves bromocriptine-induced postpartum hypogalactia in rats through the WTAP-Wnt5a-β-catenin signaling axis.

Key words: Cuiru Keli, postpartum hypogalactia, WTAP, Wnt5a, prolactin

CLC Number: